Mankind Pharma Sees Significant Open Interest Surge Amid Active Trading Environment

Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 14,471 contracts, marking a notable rise of 3,294 contracts or 29.47% from the previous open interest of 11,177. This surge coincides with a trading volume of 19,551 contracts, reflecting active market engagement.
In terms of price performance, Mankind Pharma has outperformed its sector by 2.27%, with the stock gaining 4.5% over the last two days. Today, it reached an intraday high of Rs 2,561, representing a 3.85% increase. The stock is currently trading above its 5-day, 50-day, 100-day, and 200-day moving averages, although it remains below the 20-day moving average.

Despite this positive momentum, there has been a decline in investor participation, with delivery volume dropping by 41.61% compared to the 5-day average. The stock's liquidity remains robust, accommodating trade sizes of up to Rs 2.87 crore based on 2% of the 5-day average traded value.

Overall, the increase in open interest and the stock's recent performance highlight a dynamic trading environment for Mankind Pharma, reflecting the underlying trends in the market.